One-Shot antibody boosts malaria vaccine power in kids
NCT ID NCT07208760
Summary
This study is testing whether giving a single dose of an antibody called L9LS can improve how well the body responds to a new malaria vaccine, R21/Matrix-M. It will involve 24 healthy adults and 333 healthy infants in Mali. Researchers want to see if the timing of the antibody shot affects the strength of the vaccine's protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sotuba Malaria Research and Training Center (MRTC)
Sotouba, Mali
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.